Humacyte, Inc. ·

HUMA 8-K 2026-09-28

Humacyte, Inc. (HUMA) 8-K dated 2026-09-28 — accession 0001818382-26-000011. This URL is the filing, not the HUMA hub.

Humacyte, Inc. (HUMA) common stock.

Humacyte, Inc. filed a 8-K on 2026-09-28. Accession 0001818382-26-000011.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported HUMA revenue for 2025-12-31 was $2.0M. Net income was -$40.8M. HUMA currently screens at market cap $0.

Not investment advice. The HUMA SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR

Lician Pro $19.99/mo or $149/yr